Menu Search
Equities

Reliq Health Technologies Inc

MHN2:BER

Reliq Health Technologies Inc

Actions
  • Price (EUR)0.12
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-66.10%
  • Beta--
Data delayed at least 15 minutes, as of Jan 18 2024 07:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Reliq Health Technologies Inc grew revenues 484.87% from 1.46m to 8.55m while net income improved from a loss of 11.78m to a smaller loss of 8.17m.
Gross margin60.61%
Net profit margin-3.13%
Operating margin-9.69%
Return on assets-2.92%
Return on equity-4.49%
Return on investment-4.43%
More ▼

Cash flow in CADView more

In 2022, cash reserves at Reliq Health Technologies Inc fell by 93.52k. Cash Flow from Financing totalled 7.93m or 92.78% of revenues. In addition the company used 8.03m for operations while cash from investing was breakeven.
Cash flow per share-0.0018
Price/Cash flow per share--
Book value per share0.0669
Tangible book value per share0.0669
More ▼

Balance sheet in CADView more

Reliq Health Technologies Inc uses little debt in its capital structure as supported by a debt to capital ratio of 1.62%.
Current ratio1.86
Quick ratio1.79
Total debt/total equity0.0165
Total debt/total capital0.0162
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.